Efficacy of human epididymis protein-IV as potential lung disease biomarker in comparison to Krebs von den Lungen-VI glycoprotein and apoprotein A2 among systemic sclerosis patients

Autor: Alaa Mohammad El-Salawy, Hanaa Samy El-Banna, Manal Shawky Hussein, Mohamed Hosny Fouda, Rasha Ahmad Gaber, Rasha Youssef Hagag, Souzan Ezzat Gado

Publikováno v: Egyptian Rheumatology and Rehabilitation, Vol 51, Iss 1, Pp 1-9 (2024)

Abstract Background Systemic sclerosis is a connective tissue disease of unknown etiology, characterized by vasculopathy, fibrosis, inflammation, and immune dysregulation that lead to widespread internal organs fibrosis, chronic ischemia, and subsequ

Externí odkaz: https://doaj.org/article/6225aff94f914f2c81242cb8e394b5b9

An exploratory investigation of lipid-lowering potential of spirulina (Arthrospira platensis) targeting apoprotein-E in chronic hyperlipidemic wistar albino rats

Autor: Anum Nazir, Mahr Un Nisa, Mohamed H. Mahmoud, Ahmed M. El-Gazzar, Eliasse Zongo

Publikováno v: Cogent Food & Agriculture, Vol 10, Iss 1 (2024)

Spirulina (Arthrospira platensis) is the most famous species of microalgae and is a possible source of important chemicals and therapeutic metabolites with a variety of pharmacological effects. This study investigated the nutritional profile of spiru

Externí odkaz: https://doaj.org/article/64b8241ac32b4cd2b36d61c61a91b2fe

Apoprotein Research

Autor: Nelson, Rachel T., Penfield, Linda R.

An apoprotein a protein that is normally attached to second molecule that is not a polypeptide, from which it has become disassociated. For example: ferritin that lacks the ferric hydroxide core could be called apoferritin. Lipid supply is a determin

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Polynesian-specific SLC22A3 variant associates with low plasma lipoprotein(a) concentrations independent of apo(a) isoform size in males.

Autor: Wang Q; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre, New Zealand., McCormick S; Maurice Wilkins Centre, New Zealand.; Department of Biochemistry, University of Otago, Dunedin, New Zealand., Leask MP; University of Alabama, Birmingham, USA., Watson H; Paratene Ngata Research Centre, Ngati Porou Oranga, Te Puia Springs, New Zealand., O'Sullivan C; Maurice Wilkins Centre, New Zealand.; Moko Foundation, Kaitaia, New Zealand., Krebs JD; Centre for Endocrine, Diabetes and Obesity Research, Te Whatu Ora New Zealand Capital, Coast and Hutt Valley, Wellington, New Zealand.; Department of Medicine, University of Otago, Wellington, New Zealand., Hall R; Department of Medicine, University of Otago, Wellington, New Zealand., Whitfield P; Department of Medicine, University of Otago, Wellington, New Zealand., Merry TL; Maurice Wilkins Centre, New Zealand.; Department of Nutrition, University of Auckland, New Zealand., Murphy R; Maurice Wilkins Centre, New Zealand.; Auckland Diabetes Center, Te Whatu Ora Health New Zealand, Te Tokai Tumai, New Zealand.; Department of Medicine, University of Auckland, Auckland, New Zealand., Shepherd PR; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.; Maurice Wilkins Centre, New Zealand.

Publikováno v: Bioscience reports [Biosci Rep] 2024 Jul 31; Vol. 44 (7).